Esperion Therapeutics
ESPR
#6751
Rank
โ‚น40.38 B
Marketcap
โ‚น204.96
Share price
-3.57%
Change (1 day)
159.00%
Change (1 year)

Esperion Therapeutics (ESPR) - Total debt

Total debt on the balance sheet as of June 2024 : โ‚น22.69 Billion

According to Esperion Therapeutics's latest financial reports the company's total debt is โ‚น22.69 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Esperion Therapeutics - Total debt on balance sheet (from 2000 to 2024)

Total debt by year

Year Total debt Change
2023-12-31โ‚น22.15 B2.62%
2022-12-31โ‚น21.59 B11.5%
2021-12-31โ‚น19.36 B42.83%
2020-12-31โ‚น13.55 B12065.57%
2019-12-31โ‚น0.11 B
2018-12-31N/A-100%
2017-12-31โ‚น66.72 M-64.05%
2016-12-31โ‚น0.18 B-34.93%
2015-12-31โ‚น0.28 B-7.57%
2014-12-31โ‚น0.30 B
2012-12-31โ‚น1.24 B241.69%
2011-12-31โ‚น0.36 B
2002-12-31โ‚น0.42 B37.71%
2001-12-31โ‚น0.30 B76.15%
2000-12-31โ‚น0.17 B43.87%
1999-12-31โ‚น0.12 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
โ‚น3.15 B-86.08%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น50.83 B 123.93%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.618 T 24,652.26%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น228.06 B 904.70%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น37.50 B 65.22%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น8.50 B-62.55%๐Ÿ‡บ๐Ÿ‡ธ USA